92589 ⎘
Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
N-Substituted Phenylalkylamines and Their Use as Therapeutic Agents
#2NOVEL MOLECULES
#35-METHOXYMETHYL AND 5-HYDROXYMETHYL PHENETHYLAMINES
#4NOVEL AROMATIC MOLECULES
#5COMPOUNDS
#6THERAPEUTIC PHENETHYLAMINE COMPOSITIONS AND METHODS OF USE
#7METHODS FOR PREPARING MESCALINE
#8THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF
#9NOVEL AROMATIC MOLECULES
#10PHENETHYLAMINES AND METHODS OF PREPARATION THEREOF
#11THERAPEUTIC PHENETHYLAMINE COMPOSITIONS AND METHODS OF USE
#12SUBSTITUTED PHENYLALKYLAMINES
#13COMPOSITION, COMPOUND, RESIN, SUBSTRATE TREATMENT METHOD, AND MANUFACTURING METHOD FOR SEMICONDUCTOR DEVICE
#14COMPOUNDS AND METHODS FOR TREATING 5-HT2 RESPONSIVE CONDITIONS
#15PHENETHYLAMINE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE
#16DEUTERATED ANALOGS AND DERIVATIVES OF 4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE AND USES THEREOF
#17SELECTIVE, PARTIAL, AND ARRESTIN-BIASED 5-HT2A AGONISTS WITH UTILITY IN VARIOUS DISORDERS
#184-ALKENYL AND 4-ALKYNYL PHENETHYLAMINE DERIVATIVES AND RELATED COMPOUNDS WITH MODIFIED DOM-LIKE ACTION
#19PHENALKYLAMINES AND METHODS OF MAKING AND USING THE SAME
#20NOVEL AROMATIC MOLECULES
#21NON-HALLUCINOGENIC ARIADNE ANALOGS FOR TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS
#22Substituted piperazines as disrupters of AB42 oligomer formation
#23Therapeutic phenethylamine compositions and methods of use
#24PHENALKYLAMINES AND METHODS OF TREATING MOOD DISORDERS
#25MESCALINE DERIVATIVES WITH MODIFIED ACTION
#26Alkoxy compounds for disease treatment
#27Aminoadamantyl nitrate compounds and their use to treat CNS disorders
#28MESCALINE DERIVATIVES WITH MODIFIED ACTION
#29SMALL MOLECULE INHIBITORS OF Id PROTEINS
#30MESCALINE DERIVATIVES WITH MODIFIED ACTION
#31Method for functionalization of an aromatic amino acid or a nucleobase
#32COMPOSITIONS AND METHODS OF USE COMPRISING SUBSTANCES WITH NEURAL PLASTICITY ACTIONS ADMINISTERED AT NON-PSYCHEDELIC/PSYCHOTOMIMETIC DOSAGES AND FORMULATIONS
#33High penetration drugs and their compositions thereof for treatment of Parkinson diseases
#34ACETYLATED PRODRUGS FOR DELIVERY ACROSS THE BLOOD-BRAIN BARRIER
#35Processes for the preparation of zuclomiphene and intermediates thereof
#36Asymmetric synthesis of alpha-branched chiral amines
#37Alkoxy compounds for disease treatment
#38Aminoadamantyl nitrate compounds and their use to treat CNS disorders
#39Substituted amines as disrupters of ABETA42 oligomer formation
#40Compounds for Increasing Lipid Synthesis and Storage
#41BENZOQUINOLONE INHIBITORS OF VMAT2
#42Hole transporting organic molecules containing enamine groups for optoelectronic and photoelectrochemical devices
#43Small molecule drugs and related methods for treatment of diseases related to Aβ42 oligomer formation
#44Alkoxy compounds for disease treatment
#45Compositions and methods for treatment of prostate carcinoma
#46Synergistic compositions
#47ERR modulators and uses thereof
#48Lipids and lipid compositions for the delivery of active agents
#49Alkoxy compounds for disease treatment
#50Monamine and monoamine derivatives as inhibitors of leukotriene A4 hydrolase
#51Process for the preparation of Verapamil hydrochloride
#52Diphenethylamine derivatives which are inter alia useful as analgesics and method for their production
#53Dimethoxyphenyl inhibitors of vesicular monoamine transporter 2
#54High penetration drugs and their compositions thereof for treatment of Parkinson diseases
#55Synergistic compositions
#56Compositions and methods for treatment of prostate carcinoma
#57BENZOQUINOLONE INHIBITORS OF VMAT2
#58Alkoxy compounds for disease treatment
#59Compounds for increasing lipid synthesis and storage
#60MAO-B selective inhibitor compounds, pharmaceutical compositions thereof and uses thereof
#61T type calcium channel inhibitors
#62Bilaterally-substituted tricyclic compounds for the treatment of human immunodeficiency virus type-1 (HIV-1) infection and other diseases
#63Synergistic compositions
#64Method for producing novel organometallic complex and amine compound
#65BENZOQUINOLINE INHIBITORS OF VMAT 2
#66Antimicrobial compounds, compositions and methods of use thereof
#67BAX agonist, compositions, and methods related thereto
#68Alkoxy compounds for disease treatment
#69DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE BETA2 ADRENERGIC RECEPTOR
#70Process for the Synthesis of Arformoterol
#71Treatment of cancer, inflammatory disease, and autoimmune disease
#72Lipids and lipid compositions for the delivery of active agents
#73BAX agonist, compositions, and methods related thereto
#74Halogenated phenols for diagnostics, antioxidant protection and drug delivery
#75Halogenated phenols for diagnostics, antioxidant protection and drug delivery
#76Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof
#77Alkoxy compounds for disease treatment
#78Bicyclic aryl sphingosine 1-phosphate analogs
#79Halogenated phenols for diagnostics, antioxidant protection and drug delivery
#80HALOGENATED PHENOLS FOR DIAGNOSTICS, ANTIOXIDANT PROTECTION AND DRUG DELIVERY
#81HALOGENATED PHENOLS FOR DIAGNOSTICS, ANTIOXIDANT PROTECTION AND DRUG DELIVERY
#82Alkoxy compounds for disease treatment
#83Alkoxy compounds for disease treatment
#84Alkoxy compounds for disease treatment
#85Sphingosine kinase inhibitors
#86Compound having S1P receptor binding potency and use thereof
#871,5-diphenyl-penta-1,4-dien-3-one compounds
#88BENZOQUINOLONE INHIBITORS OF VMAT2
#89Beta-3 receptor ligands and their use in therapy
#90Process for the synthesis of arformoterol
#91Compositions and methods for the treatment of infectious diseases
#92Opioid receptor antagonists
#93Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptors
#94DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE BETA2 ADRENERGIC RECEPTOR
#95Bicyclic aryl sphingosine 1-phosphate analogs
#96Heterocyclyl-substituted-ethylamino-phenyl derivatives, their preparation and use as medicaments
#97Hapten compounds and compositions and uses thereof
#98Beta-3 receptor ligands and their use in therapy
#99Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof
#100Alkoxy compounds for disease treatment
#101N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor
#102SYNTHESIS OF PHENOXYACETIC ACID DERIVATIVES
#103T type calcium channel inhibitors
#104Co-Crystals of Calixarenes and Biologically Active Molecules
#105PROCESS FOR PREPARING N-METHYL-3, 4-DIMETHOXYPHENYLETHYLAMINE
#106THYRONAMINE DERIVATIVES AND ANALOGS AND METHODS OF USE THEREOF
#107Medicinal Compounds
#108Novel Compounds Active as Muscarinic Receptor Antagonists
#109Crystal polymorph of hydroxynorephedrin derivative hydrochloride
#110Crystal of hydroxynorephedrin derivative hydrochloride ¼ hydrate
#111Opioid receptor antagonists
#112Compound having S1P receptor binding potency and use thereof
#113Sphingosine kinase inhibitors
#114Diaryl ether βadrenergic receptor agonists
#115Intermediates in producing phenoxyacetic acid derivatives and method of using the same
#116Intermediates in producing phenoxyacetic acid preventives and method of using the same
#117Intermediates in producing phenoxyacetic acid derivatives and method of using the same
#118Calixarenes as Inhibitors of Protein Kinase B
#119Substituted tetrahydroisoquinoline compounds, methods of making, and their use
#120CALCILYTIC COMPOUNDS
#121Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof
#122Method and apparatus for performing micro-scale chemical reactions
#123Guanidine and amidine acid derivatives and analogs and methods of using the same
#124Phenetanolamine derivatives
#125Method for selective reduction of aromatic compounds
#126N-(2-ARYLETHYL)BENZYLAMINES AS ANTAGONISTS OF THE 5-HT6 RECEPTOR
#127Diphenylether amide derivatives as opioid receptor antagonists
#128Sphingosine kinase inhibitors
#129Calcium receptor-active molecules
#130Phenyl and pyridyl LTA4H modulators
#131Inhibitor against biosynthesis of abscisic acid
#132Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
#133Intermediates in producing phenoxyacetic acid derivatives and method of using the same
#134Nitrogen-containing ligands
#135Aminoalcohol derivatives
#136Thyronamine derivatives and analogs and methods of use thereof
#137Anti tubercular drug: compositions and methods
#138Diaryl ether β2 adrenergic receptor agonists
#139N-(2-Arylethyl) benzylamines as antagonists of the 5-HTreceptor
#140Phenethanolamine derivatives
#141Manufacture of phenyl ethylamine compounds, in particular venlafaxine
#142Beta secretase inhibitors
#143hPPARs activators
#144Calcium receptor antagonists
#145Thyronamine derivatives and analogs and methods of use thereof
#146Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
#147Abscisic acid biosynthesis inhibitor